パンデミック中の急速な臨床研究:学んだ教訓と今後の道
Florence Ader1, Éloïse Aubret2, Nathalie Bergaud2
1Département des Maladies infectieuses et tropicales, Hospices Civils de Lyon F-69004 Lyon, France; Centre International de Recherche en Infectiologie (CIRI), Inserm 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Univ Lyon F-69007, France.
Infectious diseases now
|August 23, 2025
まとめ
新興感染症 (EID) のための全国運用研究ネットワーク,OPEN-ReMIEは,疫病の際に病院ベースの臨床研究を加速するために設立されました. 準備と対応能力の強化を目的としており,国内と国際の研究協力において
科学分野:
- 公衆衛生
- 感染症
- 臨床研究ネットワーク
背景:
- COVID-19 パンデミックは,新興感染症 (EID) のための強力な国家研究ネットワークの必要性を強調しました.
- 疫病やパンデミックの可能性のあるEIDに対する効果的な準備と対応のために,既存の構造を強化する必要がありました.
研究 の 目的:
- OPEN-ReMIE (EIDのためのオペレーション・リサーチ・ネットワーク) の全国ネットワークを確立し,記述する.
- 疫病/パンデミック条件下で病院ベースの臨床研究を加速させるというミッションを概説する.
- 国家準備と国際協力における役割を詳細に述べる.
主な方法:
- このネットワークはフランス2030によって資金提供され,国立研究機関 (ANR) によって運営されています.
- 危機間および危機モードでの運用性のためのガバナンス構造を備えています.
- 6つの作業パッケージは,規制問題,現場管理,方法論,実験室資源,医薬品供給,訓練/コミュニケーションをカバーしています.
主要な成果:
- OPEN-ReMIEは,国家準備タスクフォースとして構成されています.
- スポンサー,規制機関,患者会など様々な利害関係者のための中心的なポイントとして機能します.
- ネットワークはより大きな欧州のコンソーシアムに統合され,国際的なプラットフォームと連携しています.
結論:
- OPEN-ReMIEは,EIDの臨床研究における国家能力を強化するために不可欠です.
- このネットワークは,将来の疫病やパンデミックの脅威に対する備えと対応を改善することを目的としています.
- 運営の枠組みと協力的なアプローチは成功の鍵です.
関連する概念動画
Steps in Outbreak Investigation
199
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
199
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Study Designs in Epidemiology
415
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
415
Ethics in Research
24.0K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
24.0K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K


